BioSpace News Archive

We are committed to powering the next generation of precision therapeutics with AI-driven spatial biomarkers and diagnostics.

Tessera Therapeutics is pioneering Gene Writing™—a new genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source.

Incyclix Bio, LLC is a next-generation cell cycle control company, advancing precision treatments that target the aberrant proliferation driving many cancers.

Catalyst Clinical Research LLC, a clinical development organization providing highly customizable clinical research solutions to the global biopharmaceutical and biotechnology industries through two established brands: Catalyst Flex and Catalyst Oncology.

Bend Bioscience provides a collaborative R&D approach, specializing in particle engineering, drug delivery, drug development and manufacturing expertise to the pharmaceutical industry.

At Inventprise, developing innovative and widely available vaccines is in our DNA. By producing targeted vaccines for populations worldwide, we’re addressing global health inequalities and empowering people to live healthy lives—no matter where they live.

ProfoundBio is now part of Genmab

InduPro is bringing life-changing therapies to patients through novel cell-surface platform technologies.

Cabaletta Bio is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies that have the potential to provide a deep and durable, perhaps curative, treatment for patients with autoimmune diseases.

Zephyr AI uses large complex data and proprietary algorithms to discover new insights and opportunities for Personalized/Precision Medicine, Drug Discovery, Drug Rescue, and Clinical Decision Support. Zephyr AI partners with leading health systems, health insurance plans, and biotechnology pioneers to improve Quality, Outcomes and Costs.